Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Dis ; 7: e2103, 2016 Feb 18.
Article in English | MEDLINE | ID: mdl-26890142

ABSTRACT

Neutrophil granulocytes are innate effector cells of the first line of defense against pyogenic bacteria. Neutrophil lifespan is short, is prolonged by pro-inflammatory stimuli, controls functionality of the cells and can determine tissue damage. Experimental analysis of primary neutrophils is difficult because of their short lifespan and lack of possibilities of genetic manipulation. The Hoxb8 system of neutrophil differentiation from immortalized progenitor cells offers the advantage of unlimited production of neutrophils in vitro as well as easy genetic modification. We here use this system to analyze the role of the poorly characterized anti-apoptotic B-cell lymphoma protein 2 (Bcl-2) family member A1/Bfl-1 (Bcl-2-related protein A1) for survival and homeostasis of neutrophils and of neutrophil progenitors. Low constitutive mRNA and protein expression of A1 was detected, while A1 was transiently upregulated early during differentiation. Pro-inflammatory stimuli caused strong, mainly transcriptional, A1 upregulation, in contrast to posttranscriptional regulation of Mcl-1 (induced myeloid leukemia cell differentiation protein). Inhibitor studies showed that phosphoinositide-3 kinase (PI3K)/Akt and Janus kinase (JAK)/signal transducer and activator of transcription (STAT) is required for A1 expression and survival of progenitors and mature neutrophils. ShRNA-mediated constitutive A1 knockdown (KD) impaired maintenance of progenitors. ShRNA experiments further showed that A1 was required early during neutrophil differentiation as well as in mature neutrophils upon pro-inflammatory stimulation. Our data further indicate differential regulation of the two anti-apoptotic proteins A1 and Mcl-1. Relevant findings were confirmed in primary human neutrophils. Our data indicate that A1, in addition to the well-established Mcl-1, substantially contributes to neutrophil survival and homeostasis. A1 may thus be a promising target for anti-inflammatory therapy.


Subject(s)
Janus Kinases/metabolism , Minor Histocompatibility Antigens/metabolism , Neutrophils/cytology , Neutrophils/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Animals , Apoptosis/physiology , Cell Differentiation/physiology , Granulocytes/cytology , Granulocytes/metabolism , Homeostasis , Humans , Mice , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction
2.
Cell Death Differ ; 18(11): 1805-14, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21660046

ABSTRACT

Neutrophils enter the peripheral blood from the bone marrow and die after a short time. Molecular analysis of spontaneous neutrophil apoptosis is difficult as these cells die rapidly and cannot be easily manipulated. We use conditional Hoxb8 expression to generate mouse neutrophils and test the regulation of apoptosis by extensive manipulation of B-cell lymphoma protein 2 (Bcl-2)-family proteins. Spontaneous apoptosis was preceded by downregulation of anti-apoptotic Bcl-2 proteins. Loss of the pro-apoptotic Bcl-2 homology domain (BH3)-only protein Bcl-2-interacting mediator of cell death (Bim) gave some protection, but only neutrophils deficient in both BH3-only proteins, Bim and Noxa, were strongly protected against apoptosis. Function of Noxa was at least in part neutralization of induced myeloid leukemia cell differentiation protein (Mcl-1) in neutrophils and progenitors. Loss of Bim and Noxa preserved neutrophil function in culture, and apoptosis-resistant cells remained in circulation in mice. Apoptosis regulated by Bim- and Noxa-driven loss of Mcl-1 is thus the final step in neutrophil differentiation, required for the termination of neutrophil function and neutrophil-dependent inflammation.


Subject(s)
Apoptosis , Neutrophils/physiology , Proto-Oncogene Proteins c-bcl-2/metabolism , Animals , Apoptosis Regulatory Proteins/metabolism , Bcl-2-Like Protein 11 , Down-Regulation , Homeodomain Proteins/metabolism , Membrane Proteins/metabolism , Mice , Myeloid Cell Leukemia Sequence 1 Protein , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , bcl-X Protein/metabolism
3.
Infect Immun ; 69(11): 7121-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11598088

ABSTRACT

Chlamydia pneumoniae is an obligate intracellular bacterium which frequently causes airway infection in humans and has been implicated in atherosclerosis. Here we show that infection with C. pneumoniae protects HeLa human epithelioid cells against apoptosis induced by external stimuli. In infected HeLa cells, apoptosis induced by staurosporine and CD95-death-receptor signaling was strongly reduced. Upon treatment with staurosporine, generation of effector caspase activity, processing of caspase-3 and caspase-9 and cytochrome c redistribution were all profoundly inhibited in cells infected with C. pneumoniae. Bacterial protein synthesis during early infection was required for this inhibition. Furthermore, cytochrome c-induced processing and activation of caspases were inhibited in cytosolic extracts from infected cells, suggesting that a C. pneumoniae-dependent antiapoptotic factor was generated in the cytosol upon infection. Infection with C. pneumoniae failed to induce significant NF-kappaB activation in HeLa cells, indicating that no NF-kappaB-dependent cellular factors were involved in the protection against apoptosis. These results show that C. pneumoniae is capable of interfering with the host cell's apoptotic apparatus at probably at least two steps in signal transduction and might explain the propensity of these bacteria to cause chronic infections in humans.


Subject(s)
Apoptosis , Chlamydophila pneumoniae/pathogenicity , 2,4-Dinitrophenol/pharmacology , Bacterial Proteins/biosynthesis , Caspase 3 , Caspase 9 , Caspases/metabolism , Cytochrome c Group/metabolism , Enzyme Activation , HeLa Cells , Humans , Mitochondria/metabolism , NF-kappa B/metabolism , Transcription, Genetic , Tumor Cells, Cultured , fas Receptor/pharmacology
4.
Biochem Biophys Res Commun ; 276(3): 855-61, 2000 Oct 05.
Article in English | MEDLINE | ID: mdl-11027559

ABSTRACT

The P35 protein derived from the baculovirus Autographa californica NPV has been characterized as an inhibitor of apoptotic cell death in a great number of organisms and situations. This potential has been further mapped to the capacity of P35 to inhibit all caspases investigated. Here we show that P35 does not inhibit caspase-9 activity in a cell-free system of mammalian caspase activation. In cell extracts, cytochrome c addition led to the activation of caspase-9, -3 and -7. When cytosolic extract from cells expressing P35 was added, caspase-9-mediated maturation of caspase-3 proceeded normally but caspase-3-mediated further events were prevented, such as complete processing of caspase-3, processing of caspase-7 and the appearance of DEVD-cleaving activity. The P35 protein from Bombyx mori NPV, which has been reported to have a much weaker anti-apoptosis activity in vivo, was found also to have significant caspase-3-inhibiting activity. These data suggest that P35 evolved specifically to inhibit effector rather than initiator caspases.


Subject(s)
Apoptosis , Caspases/metabolism , Nucleopolyhedroviruses , Viral Proteins/metabolism , Blotting, Western , Caspase 3 , Caspase 7 , Caspase 9 , Caspase Inhibitors , Cell Extracts , Cell Line, Transformed , Cell-Free System/drug effects , Cell-Free System/enzymology , Cell-Free System/metabolism , Cysteine Proteinase Inhibitors/pharmacology , Cytochrome c Group/metabolism , Deoxyadenine Nucleotides/metabolism , Deoxyadenine Nucleotides/pharmacology , Enzyme Activation/drug effects , Enzyme Precursors/metabolism , Humans , Inhibitor of Apoptosis Proteins , Jurkat Cells , Protein Processing, Post-Translational/drug effects , Substrate Specificity , Transfection , Viral Proteins/genetics
5.
Biochem Biophys Res Commun ; 261(1): 71-8, 1999 Jul 22.
Article in English | MEDLINE | ID: mdl-10405325

ABSTRACT

Cytochrome c is thought to play an important role in the initiation of apoptosis following its release from mitochondria. It is controversial whether such release is also involved in caspase activation and apoptotic cell death after ligation of the cell surface molecule Fas. We addressed this issue by investigating cells from the human cell lines Jurkat and SKW6 which had been treated with the inhibitor of the mitochondrial F0/F1-ATPase, oligomycin. Oligomycin-treatment led, over a wide range of concentrations, to ATP-depletion and, at similar concentrations, abrogated the appearance of caspase-3-like activity caused by stauroporine. Electroporation of cytochrome c protein into intact cells induced caspase activation in both cell lines and significant nuclear apoptosis in Jurkat cells. In ATP-depleted cells, electroporation of cytochrome c induced neither caspase activation nor nuclear fragmentation. Fas-induced caspase activation and nuclear apoptosis, however, were unaffected by the depletion of ATP. Thus, cytochrome c is unlikely to be an important factor in Fas-induced cell death.


Subject(s)
Apoptosis , Caspases/metabolism , Cytochrome c Group/physiology , fas Receptor/physiology , Adenosine Triphosphate/metabolism , Apoptosis/drug effects , Coumarins/metabolism , Cytochrome c Group/administration & dosage , Dose-Response Relationship, Drug , Electroporation , Enzyme Activation/drug effects , Humans , Jurkat Cells , Oligomycins/pharmacology , Oligopeptides/metabolism , Proton-Translocating ATPases/antagonists & inhibitors , Signal Transduction/drug effects , Staurosporine/antagonists & inhibitors , Staurosporine/pharmacology , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...